Iron deficiency anemia is the most common cause of anemia during pregnancy. (WHO) defines anemia in pregnancy as hemoglobin (Hb <11 g/dL), or hematocrit (Hct <33%), at any time during the pregnancy.¹ Anemia affects 20% of pregnant women; with iron, folic acid, or combined deficiencies being the most common causes. Based on WHO’s statistics, prevalence of anemia in pregnancy accounts for about 14% in developed and 51%in developing countries; India contributes to 65-75% of the cases.² Risk factors for iron deficiency anemia (IDA) among pregnant women include a diet lacking adequate iron consumption, obesity, increased parity, low socioeconomic status, low educational attainment, ethnic minority etc.Pregnancy-related factors that worsens preexisting anemia in Indian women include increased iron and nutritional needs, excessive blood loss during labor, infections during the prenatal and postnatal phases and rapid successive pregnancy.³ In pregnant women, IDA is associated with an increased risk of preterm labour, low neonatal weight and perinatal complications. Severe IDA is also associated with increased perinatal and maternal mortality due to lower tolerance to excessive blood loss during delivery and increased risk of infections. Iron deficiency may hinder defective myelination in infants, so that the resulting anemia produces long-lasting defects in mental development and performance that may further impair the child learning capacity. Therefore, every case of anemia should be treated in pregnancy.⁴Therapy for IDA includes dietary modification, oral iron supplementation, intravenous iron and blood transfusion. WHO suggests 30-60 mg per day iron supplementation for all pregnant women .¹ The main issue with oral iron therapy is compliance due to associated gastrointestinal side effects like bloating, diarrhea , heartburn, nausea, constipation, and dark stools.⁵ Intramuscular iron should be avoided as it is painful, requires multiple injections, stains the buttock, and is associated with gluteal sarcoma .Parentral iron is expensive and is associated with serious adverse effects (SAEs), including anaphylaxis and infusion minor reactions.^1,6 Thus, the necessity for an alternative medical system emerges to minimise IDA’s complications and recurrence while providing minimal adverse effects and most economical treatment. Unani system of medicine provides cost effective and easily available medications which are relatively free from side effects. Hence, A randomized standard controlled clinical study is contemplated to evaluate and validate the therapeutic effect of Sharbat Anar Sheerin ^7,8(Punica granatum Linn) on scientific parameters in IDA during pregnancy.